Erasca has streamlined its pipeline, now focusing on a phase 3 trial for Naporafenib targeting NRAS-mutant melanoma. Read ...

It’s comfortable, economical, roomy and cheap – but doesn’t feel remotely budget. Could this be the ultimate family transport ...

FTNT's ability to monetize its educational initiatives and cutting-edge cybersecurity solutions make the stock worth buying ...

Soft2Bet, Betsson Group and Kaizen Gaming were among the standout winners at the 2024 SBC Awards, marking the event's debut ...